Covid-19 Vaccine Shortage Hits Pune’s Inoculation Drive
Pune, Maharashtra's second-largest city after Mumbai, was inoculating around 25,000-27,000 people per day when it faced a shortage of vaccines. As a result, it has stopped vaccinating those aged above 45 years of age since May 1.
“We have received 5,000 doses of Covishield (vaccine) to vaccinate people in the age group of 18-44 years,” Dr. Ashish Bharati, health chief of Pune Municipal Corporation, told BloombergQuint over the phone on May 4. “We have activated two vaccine centres for the same, where we're administering 350 doses each per day. Our target is to vaccinate 700 people per day in this age group.”
This comes at a time when as many as 3.57 lakh people tested positive for the virus across India and more than 3,000 deaths were recorded in the 24 hours till 8 a.m. on May 4, according to data from the Health Ministry, taking the total number of confirmed infections above 2 crore.
Vaccination Status For 18-44 Age Group
- May 1: 132 doses.
- May 2: 380.
- May 3: 665.
So far, the city has vaccinated around 8.4 lakh people, Dr. Bharati said. Out of these, around 7 lakh doses were Serum Institute of India Ltd.'s Covishield and the remaining Bharat Biotech International Ltd.'s Covaxin.
The civic body is following up with the state government over availability of new shots so that it can resume vaccinating people who are aged above 45 years, the official said, adding it will require around 80 lakh doses to administer two shots each to all eligible people.
The PMC recorded 3,003 new Covid-19 infections and 25 deaths on May 4.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.